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Phosphatase and tensin homolog deleted on chromosome
ten (PTEN) is an important regulator of phosphatidylino-
sitol-(3,4,5,)-trisphosphate signalling, which controls cell
growth and differentiation. However, PTEN is also highly
expressed in the adult brain, in which it can be found in
dendritic spines in hippocampus and other brain regions.
Here, we have investigated specific functions of PTEN in
the regulation of synaptic function in excitatory hippo-
campal synapses. We found that NMDA receptor activation
triggers a PDZ-dependent association between PTEN and
the synaptic scaffolding molecule PSD-95. This association
is accompanied by PTEN localization at the postsynaptic
density and anchoring within the spine. On the other
hand, enhancement of PTEN lipid phosphatase activity
is able to drive depression of AMPA receptor-mediated
synaptic responses. This activity is specifically required
for NMDA receptor-dependent long-term depression
(LTD), but not for LTP or metabotropic glutamate receptor-
dependent LTD. Therefore, these results reveal PTEN as a
regulated signalling molecule at the synapse, which
is recruited to the postsynaptic membrane upon NMDA
receptor activation, and is required for the modulation of
synaptic activity during plasticity.
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Introduction
Phosphatase and tensin homolog deleted on chromosome ten
(PTEN; also known as MMAC1 or TEP1) was originally
cloned as a tumour suppressor protein (Li et al, 1997; Steck
et al, 1997). PTEN antagonizes phosphatidylinositosl-30-kinase
(PI3K) signalling by dephosphorylating phosphatidylinositol-
(3,4,5,)-trisphosphate (PIP3) to generate phosphatiylinositol-
(4,5)-bisphosphate (PIP2) (Maehama and Dixon, 1999). As a
negative regulator of the PI3K-PIP3 pathway, PTEN restrains
cell proliferation and survival during embryogenesis.
Consistent with this developmental function, PTEN null
mice die during embryogenesis, whereas heterozygotes are
tumour prone and display enlargement of multiple organs
(Stiles et al, 2004). Similarly, alterations in the function of
PTEN are of major relevance for the incidence of a wide
variety of human cancers (Li et al, 1997; Pendaries et al,
2003).
In the central nervous system, PTEN is expressed in most,
if not all neurons. It is present in dendrites and spines of
cerebral cortex, cerebellum, hippocampus and olfactory bulb
(Perandones et al, 2004). Mutation or inactivation of PTEN
contributes to brain tumours, macrocephaly, seizures and
ataxia (Backman et al, 2001; Kwon et al, 2001; Eng, 2003).
PTEN mutations have been also associated with mental
retardation and autism spectrum disorders (Butler et al,
2005; Kwon et al, 2006). At the cellular level, neurons lacking
PTEN develop larger and more branched dendrites, which
harbour more synapses (Jaworski et al, 2005; Kwon et al,
2006; Fraser et al, 2008). Therefore, it is likely that the
neurological deficits associated to PTEN mutations are
derived from aberrant neuronal growth and connectivity
during brain development. These widespread morphological
changes may also be the reason for the pleiotropic effects on
synaptic function and plasticity that have been reported
for mice with reduced PTEN expression (Wang et al, 2006;
Fraser et al, 2008).
Besides these developmental aspects, the PIP3 pathway has
specific functions at synapses in differentiated neurons. For
example, acute blockade of PI3K, the PIP3 synthesizing
enzyme, has been shown to impair some forms of memory
formation (Chen et al, 2005) and long-term potentiation
(LTP) in hippocampal slices (Sanna et al, 2002; Tang et al,
2002; Cammalleri et al, 2003; Opazo et al, 2003). The PIP3
pathway has also been linked to AMPAR trafficking (Qin et al,
2005) and synaptic localization (Arendt et al, 2010) in hippo-
campal neurons. However, a specific function for PTEN in
synaptic transmission or plasticity in developed neurons has
not been pinpointed yet.
From a mechanistic point of view, PTEN possesses a PDZ-
binding motif at its C-terminus (residues Thr401-Lys402-Val403-
COOH), which interacts with multiple PDZ domain-containing
proteins, such as the scaffolding proteins MAGI-1/2/3, hDlg/
SAP97 and the Ser/Thr kinase MAST205 (Bonifant et al,
2007). The physiological consequences of these PDZ-depen-
dent interactions remain poorly characterized; however, it has
been shown that the binding of PTEN to specific PDZ domain-
containing proteins contributes to PTEN protein stability
(Valiente et al, 2005). Nevertheless, no interaction between
PTEN and synaptic PDZ proteins has been reported yet.
In this study, we have investigated specific functions of
PTEN in synaptic plasticity, separate from its developmental
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functions. In particular, we have found that NMDA receptor
activation triggers the association between PTEN and post-
synaptic density-95 (PSD-95) through a PDZ-dependent inter-
action. This interaction leads to the recruitment and
anchoring of PTEN to the postsynaptic membrane, and
possibly mediates a specific function of PTEN in the expres-
sion of long-term depression (LTD). These results have
revealed PTEN as a regulated component of the intracellular
signalling machinery that controls synaptic transmission and
plasticity at hippocampal excitatory synapses.
Results
NMDA receptor activation regulates a PDZ-dependent
association between PTEN and PSD-95
As an initial step to evaluate potential functions of PTEN at
synapses, we tested its association with PSD-95, a critical
regulator of synaptic function and plasticity (El-Husseini
et al, 2000; Ehrlich and Malinow, 2004; Bhattacharyya et al,
2009). To this end, we immunoprecipitated PTEN from total
hippocampal extracts, and the presence of co-immunopreci-
pitated proteins was analysed by western blot (see Materials
and methods). As shown in Figure 1A (upper panels,
‘Control’ lanes), there was a detectable association between
PSD-95 and PTEN, which was specific, according to the
immunoprecipitation with a non-immune (‘n.i.’) antibody.
Interestingly, the association between PSD-95 and PTEN
appeared to be regulated by activity, as it was increased
after 5 min bath application of 20mM NMDA (Figure 1A,
compare ‘Control’ and ‘NMDA’ lanes), and this increase
was abolished by incubation with the NMDAR antagonist
AP5 (Figure 1B, ‘NMDAþAP5’ lanes). There was also a
weak, but detectable, interaction between PTEN and MAGI-
2, another PDZ protein known to associate with PTEN
(Wu et al, 2000). However, this interaction was not altered
by NMDAR activation (Figure 1A, middle panels).
We then tested whether the association between PSD-95
and PTEN was specifically regulated by NMDAR activation or
whether it could also be induced by other forms of neuronal
activation or depolarization. To this end, we compared the
amount of PTEN-PSD-95 co-immunoprecipitation from slices
incubated for 5 min with NMDA (20 mM), AMPA (100 mM) or
KCl (50 mM). A control immunoprecipitation with an n.i.
antibody was also carried out. Interestingly, the association
between PTEN and PSD-95 was only enhanced in slices
treated with NMDA, but not with AMPA or KCl (Figure 1C,
right panel; total protein inputs for all conditions are shown
in the left panel). To evaluate the time course of this associa-
tion, we carried out immunoprecipitations at different times
after the 5 min incubation with NMDA. As shown in Figure
1D and E, the association between PTEN and PSD-95 persists
for a period of time after the end of NMDAR activation,
although it gradually declines by the end of the time course.
It should also be pointed out that the fraction of PSD-95
associated with PTEN is rather low at all times: around 1% of
the total PSD-95 under basal conditions, roughly doubling
after NMDA induction (see quantification in Figure 1E). The
regulated association between PSD-95 and PTEN was also
observed after immunoprecipitation of PSD-95 and detection
of PTEN as a co-precipitated protein (Supplementary Figure
1). This regulation appears to be specific for PTEN, because
the interaction of PSD-95 with another PDZ-dependent
partner (the NMDA receptor) was not enhanced by this treat-
ment (Supplementary Figure 1, PTEN versus GluN1 panels).
To further characterize the structural requirements of this
regulated association between PSD-95 and PTEN, we ex-
pressed GFP-tagged PTEN in organotypic slice cultures of
rat hippocampus for 15–20 h (GFP is fused to the N-terminus
of PTEN). Confocal imaging of infected CA1 neurons showed
widespread distribution of GFP-PTEN, including distal den-
drites and spines (Figure 1F). Recombinant GFP-PTEN was
functional, as evidenced from its ability to antagonize the
PI3K/PIP3 pathway, leading to a decrease in Akt phospho-
rylation at Ser473 (Stambolic et al, 1998) (Supplementary
Figure 2A and B). Total protein extracts were prepared from
untreated slices or from slices treated with NMDA, AMPA or
KCl, as described above. Immunoprecipitations were carried
out with an anti-GFP antibody, and the immunoprecipitated
fractions were analysed by western blot. As shown in
Figure 1G, PSD-95 was co-precipitated with GFP-PTEN only
after NMDAR activation, but not after AMPA or KCl treat-
ment, similar to the results obtained with endogenous PTEN
(Figure 1C). The kinetics of GFP-PTEN association with PSD-
95 were also similar to the endogenous protein (Figure 1H,
right panels; inputs for all conditions are shown in the left
panels). As control, cytosolic GFP did not co-immunopreci-
pitate with PSD-95 with or without NMDA (Figure 1H).
PDZ-dependent interactions anchor PTEN at dendritic
spines upon NMDA receptor activation
To determine whether the association between PTEN and
PSD-95 was PDZ dependent, we generated a PTEN mutant
lacking the last four amino acids, which contain the PDZ
ligand motif (-ITKV*). We then carried out co-immunopreci-
pitations from slices expressing GFP, full-length GFP-PTEN or
the truncated form of PTEN lacking its PDZ-binding motif
(GFP-PTEN-DPDZ) (see Supplementary Figure 2C for a wes-
tern blot analysis of the expression of this and other PTEN
derivatives used in this study). As shown in Figure 2A (upper
right panel), the association with PSD-95 was only detectable
with GFP-PTEN, but not with GFP-PTEN-DPDZ or cytosolic
GFP, and only after NMDAR activation. This result confirms
that the association between PTEN and PSD-95 requires the
PDZ motif at the PTEN C-terminus.
PSD-95 is a well-known synaptic scaffolding molecule that
organizes multiple signalling complexes at the synapse
(Sheng, 2001). Therefore, our biochemical results described
above suggest that PTEN may be recruited and anchored at
synapses after NMDAR activation. To test this possibility, we
evaluated real-time dynamics of PTEN in dendritic spines
using fluorescence recovery after photobleaching (FRAP; see
fluorescence images from a representative experiment in
Figure 2B). GFP-tagged PTEN was expressed in organotypic
hippocampal slices, and the NMDA treatment was carried out
as described above. Spines expressing GFP-PTEN were photo-
bleached and the extent of fluorescence recovery was mea-
sured before and after NMDAR activation (‘þ 5’, ‘þ 15’ and
‘þ 25’ min; for simplicity, the ‘þ 15-min’ time point is only
shown in the summary Figure 2F). As shown in Figure 2C
(white circles), approximately 50% of the GFP-PTEN signal is
recovered in the spine over a time course of 10–20 s, arguing
that 50% of GFP-PTEN is stable in spines (over this period of
time) under basal conditions. Intriguingly, GFP-PTEN fluore-
scence recovered to a significantly greater extent (around
PTEN is recruited to synapses for LTD
S Jurado et al
The EMBO Journal VOL 29 | NO 16 | 2010 &2010 European Molecular Biology Organization2828
70%) 5 min after the NMDA treatment (Figure 2C, red cir-
cles). This result indicates an increase in PTEN mobility
rapidly after NMDAR activation. In contrast, 20–30 min
after the NMDA treatment, the recovery of fluorescence of
GFP-PTEN in the spine was drastically reduced (around 20%;
Figure 2C, dark red circles; Figure 2F), implying that a larger
fraction of PTEN is retained in spines in a long-lasting
manner after NMDAR activation.
To test the function of PDZ interactions in this behaviour,
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Figure 1 NMDA receptor-dependent association between PTEN and PSD-95. (A) Total protein extracts from hippocampal slices were
immunoprecipitated with anti-PTEN or with a non-immune (‘n.i’) antibody (‘Control’ lanes). Some slices were treated with 20 mM NMDA
for 5 min before the immunoprecipitation (‘NMDA’ lanes). For all western blots, immunoprecipitated proteins are shown in the right panels,
and 10% of the inputs in the left panels. (B) Similar to (A), but some slices were preincubated with the NMDAR antagonist AP5 before and
during the NMDA treatment (‘NMDAþAP5’). (C) Similar to (A), with slices treated for 5 min with 20mM NMDA, 100mM AMPA, 50 mM KCl or
left untreated (‘Control’), as indicated. (D) Similar to (A), with untreated slices (‘Control’), treated with 20mM NMDA for 5 min (‘NMDA’) or
transferred to regular ACSF for 10 min (þ 100) or 25 min (þ 250) after the NMDA treatment. Asterisk (*) indicates the position of the IgG used
for immunoprecipitation. (E) Quantification of the fraction of PSD-95 co-precipitated with PTEN (as percentage from the total PSD-95 amount
in the input), from five independent experiments as the one shown in (D). The 5 min NMDA treatment is represented with a black bar.
(F) Representative confocal image showing the distribution of recombinant GFP-PTEN in soma, dendrites and spines in a hippocampal neuron
from organotypic slice cultures. (G) Hippocampal slices expressing GFP-PTEN were treated for 5 min with 20mM NMDA, 100mM AMPA, 50 mM
KCl or left untreated (‘Control’), as indicated. Total protein extracts were immunoprecipitated with anti-GFP and analysed by western blot with
anti-PSD-95 (upper panels) or anti-GFP antibodies (lower panels). Asterisk (*) indicates the position of the IgG used for immunoprecipitation.
(H) Hippocampal slices expressing GFP or GFP-PTEN, as indicated, were left untreated (‘Ctrl.’), or were treated with 20 mM NMDA for 5 min
(‘NMDA’), or were transferred to regular ACSF for 10 min after the NMDA treatment (þ 100). Total protein extracts were immunoprecipitated
with anti-GFP and analysed as in (G). Asterisk (*) indicates the position of the IgG used for immunoprecipitation.
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PTEN lacking the PDZ motif, GFP-PTEN-DPDZ. As shown in
Figure 2D, the extent of fluorescence recovery was also
greater 5 min after NMDAR activation (60% at baseline—
white circles—versus 90% 5 min after the NMDA treatment—
red circles). But in marked contrast with full-length PTEN,






































































































































Figure 2 PDZ-dependent interactions and anchoring of PTEN in spines. (A) Coimmunoprecipitation experiments were similar to those in
Figure 1H, with slices expressing GFP, GFP-PTEN or the PDZ truncated mutant GFP-PTEN-DPDZ. Slices were treated with 20mM NMDA for
5 min (‘þNMDA’) or left untreated (‘Control’). Western blot is representative of three independent experiments. (B) Representative confocal
images from an FRAP experiment. Left panel (‘baseline’) shows GFP-PTEN expression in a dendritic branch and its spines. A specific spine
(white dashed circle) was bleached (‘bleaching’) and its fluorescence partially recovered 40 s later (‘recovery’). (C) Quantitative analysis of
FRAP experiments as the one shown in (B). ‘Baseline’ (white symbols) represents FRAP experiments on GFP-PTEN-expressing slices perfused
with ACSF (untreated). The perfusion solution was then switched to ACSF containing 20 mM NMDA; 5 min later, the slices were washed again
with standard ACSF. Further FRAP images were acquired after 5, 15 and 25 min of ACSF wash (‘þ 5 min’, red symbols; ‘þ 25 min’, dark red
symbols; the ‘þ 15 min’ time courses are similar to the ‘þ 25 min’ ones and are only represented in the summary plot in (F), for simplicity).
GFP fluorescence in the spine was normalized to the fluorescence in the unbleached dendritic shaft to correct for ongoing bleaching during
imaging. Average values±s.e.m. are plotted normalized to the baseline before bleaching. Number of spines analysed were 12 (‘baseline’),
8 (‘þ 5 min’) and 9 (‘þ 25 min’) (different spines are imaged at each time point). (D, E) Similar to (C), with slices expressing GFP-PTEN-DPDZ
(D) or plain GFP (E). Number of spines analysed for GFP-PTEN-DPDZ were 7 at each time point, and for GFP 6 (‘baseline’), 5 (‘þ 5 min’) and 5
(‘þ 25 min’). (F) Recovery fractions from experiments shown in (C–E) were calculated from the fraction of fluorescence recovered 40 s (GFP-
PTEN and GFP-PTEN-DPDZ) or 4 s (GFP) after photobleaching. These values are plotted for untreated slices (0 min) or at different times after
the 5 min NMDA treatment (the ‘þ 15 min’ is not plotted in panels (C–E) for simplicity). Average values±s.e.m. are plotted for GFP-PTEN
(black symbols), GFP-PTEN-DPDZ (grey symbols) and GFP (white symbols). Statistical significance was calculated with respect to the recovery
fractions before NMDA treatment. There was no significant difference in the case of GFP-expressing neurons.
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after the NMDA treatment) and was never followed by an
enhanced retention in spines (Figure 2D, dark red circles;
Figure 2F).
As a control for potential changes in fluorophore diffusion
in spines as a result of NMDA application, we carried out
similar NMDA-FRAP experiments in slices expressing GFP. As
shown in Figure 2E and F, fluorescence recovery was nearly
complete for GFP and was not altered at any time point in
response to the NMDA treatment. In addition, neither the
rates of recovery nor the net distribution between spines and
dendrites were significantly altered for any of the recombi-
nant proteins after the NMDA treatment (Supplementary
Figure 3A and B, respectively).
Therefore, we conclude that NMDAR activation triggers a
biphasic regulation of PTEN mobility in dendritic spines.
First, there is a rapid and transient increase in mobility,
which is independent from PDZ interactions. This phase is
then followed by a longer-lasting and PDZ-dependent anchor-
ing of PTEN at the spine (Figure 2F).
Biochemical association of PTEN with the PSD after
NMDA receptor activation
To further investigate the recruitment of PTEN to the post-
synaptic machinery upon NMDAR activation, we evaluated
its association with the PSD using standard fractionation
methods (Carlin et al, 1980). To this end, we isolated synapto-
somal fractions from 3 to 4 weeks rats (see Supplementary
data). NMDARs were then activated on the purified synapto-
somes by adding 20mM NMDA and 10 mM glycine. After 5 min
incubation, NMDAR activation was stopped with AP-5 and
synaptosomes were incubated for 10 min more to allow for
PTEN stabilization. Then, the PSD fraction was isolated
as a Triton-insoluble pellet from treated and untreated
synaptosomes and was analysed by western blot (see
Supplementary data).
As shown in Figure 3, the abundance of PTEN at the PSD
was significantly enhanced (two-fold) on the synaptosomes
treated with NMDA plus glycine. The PSD enrichment of
other postsynaptic markers was not altered (PSD-95) or was
slightly decreased (GluN1 and aCaMKII) with this treatment,
ruling out potential artefacts because of non-specific protein
aggregation or precipitation. In conclusion, these experi-
ments indicate that PTEN biochemically associates with the
PSD scaffold after NMDAR activation, in agreement with its
co-precipitation with the PSD-95 protein complex.
Local redistribution of PTEN within dendritic spines
in response to NMDAR activation
To directly visualize the recruitment of PTEN to the post-
synaptic scaffold, we evaluated the ultrastructural localiza-
tion of endogenous PTEN within dendritic spines before and
after NMDA treatment. PTEN has been described to be
present in axonal and dendritic compartments in hippocam-
pal neurons (Perandones et al, 2004), but the fine-scale
distribution of PTEN in dendritic spines had never been
evaluated before.
We characterized the ultrastructural distribution of endo-
genous PTEN in close proximity to synaptic sites using
postembedding immunogold electron microscopy (see
Materials and methods; Figure 4A for representative micro-
graphs). Most synaptic PTEN immunolabelling was found in
the postsynaptic terminal (70% versus 30% presynaptic;
Figure 4B). Within the postsynaptic compartment, PTEN
labelling was predominantly located in the intracellular
space of the spine (Figure 4B, ‘Intra’), outside of the PSD
and the extrasynaptic membrane (‘Extra’).
Remarkably, upon NMDAR activation (25 min after the
NMDA treatment), PTEN fraction in the PSD increased by
six-fold, whereas the amount of PTEN in other synaptic
compartments was not significantly affected (Figure 4B,
black columns; representative micrographs in Figure 4A). In
addition, and consistent with this redistribution of PTEN into
the PSD, we observed a global shift in the population of PTEN
molecules towards the PSD (Figure 4C).
Therefore, and in agreement with our biochemical and
fluorescence imaging data, these data confirm that endogen-
ous PTEN redistributes to the postsynaptic membrane in
























































Figure 3 Enrichment of PTEN at the postsynaptic density fraction after NMDA receptor activation. (A) Representative western blot analysis of
PSD fractionations from synaptosomal preparations after NMDA receptor activation (‘þNMDA’) or untreated controls (‘NMDA’). A duplicate
of separately treated or untreated samples is presented. The starting material (synaptosomal fraction) is shown in the left lane.
(B) Quantification of PSD enrichment in NMDA-treated samples normalized to the untreated controls, from experiments as the one shown
in (A); ‘n’ represents number of independent experiments. Statistical significance was determined according to the Wilcoxon’s test for pairs of
treated–untreated samples.
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Enhancement of PTEN activity depresses AMPA
receptor-mediated synaptic transmission
As an initial step to examine PTEN function in synaptic
transmission, we overexpressed wild-type GFP-PTEN or a
catalytically dead mutant (GFP-PTEN-C124S) in CA1 neurons
from organotypic slice cultures. Importantly, expression of
this mutant produced an increase in phospho-Akt over basal
levels (Supplementary Figure 2A and B), indicating that this
construct behaves as a dominant negative against endogen-
ous PTEN activity in neurons, as it has been described earlier
in other cell types (Maehama and Dixon, 1998).
The effect of GFP-PTEN and GFP-PTEN-C124S on synaptic
transmission was evaluated by simultaneous double whole-
cell recordings from pairs of nearby infected and uninfected
CA1 neurons, under voltage-clamp configuration, while sti-
mulating presynaptic Schaffer collateral fibres (to note, under
this configuration, the recombinant proteins are always ex-
pressed exclusively in the postsynaptic neuron). As shown in
Figure 5A–C, PTEN overexpression produced a significant
depression of AMPAR-mediated currents as compared with
uninfected cells, whereas NMDAR responses remained un-
changed. In contrast, the catalytically dead mutant, PTEN-
C124S, did not alter AMPAR- or NMDAR-mediated transmis-
sion (Figure 5D–F). This result verifies that the catalytic
activity of PTEN is required for the depression of AMPAR-
mediated transmission and that this is not due to virus
infection or non-specific sequestration of regulatory proteins.
Importantly, passive membrane properties, such as input
resistance and holding current (related to basal ionic con-
ductances), and whole-cell capacitance (related to cell size)
were also similar in control and in PTEN-overexpressing
neurons (Supplementary Figure 4).
Intriguingly, the depression of AMPAR responses produced
by overexpression of PTEN was observed for basal synaptic
transmission, that is conditions under which PTEN is not
normally recruited to the postsynaptic membrane (earlier
biochemical and imaging experiments). One possible expla-
nation is that overexpressed PTEN is able to reach the
postsynaptic membrane in the absence of its regulated asso-
ciation with PDZ proteins at the postsynaptic scaffold. To test
this possibility, we carried out similar recordings with neu-
rons overexpressing the truncated PTEN mutant lacking the
PDZ motif (PTEN-DPDZ). As shown in Figure 5G–I, over-
expressed PTEN was able to depress AMPAR responses in the
absence of PDZ-dependent interactions. This depression was
still specific for AMPARs, as compared with NMDARs.
Therefore, although the recruitment of PTEN to the synaptic
scaffold requires NMDAR activation and PDZ-dependent
interactions, these requirements can be overcome by over-
expression of the recombinant protein.
The depression of basal synaptic responses produced by
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Figure 4 Local redistribution of PTEN to the postsynaptic density
after NMDA receptor activation. (A) Representative micrographs of
CA1 stratum radiatum excitatory synapses after postembedding
labelling with anti-PTEN immunogold (arrows). Presynaptic term-
inal is marked with an asterisk (*). Note accumulation of PTEN
labelling at the PSD after 5 min NMDA treatment and 25 min
recovery in ACSF (‘þ 25 min’), with respect to untreated slices
(‘Baseline’). (B) Quantification of PTEN immunogold labelling at
different compartments from electron micrographs as the ones
shown in (A). ‘PRE’: presynaptic terminal; ‘POST’: postsynaptic
terminal; ‘PSD’: postsynaptic density; ‘Extra’: perisynaptic mem-
brane lateral from the PSD; ‘Intra’: intracellular space within the
spine. Percentage of immunogold labelling per synapse was calcu-
lated as the number of gold particles at each compartment divided
by the total number of gold particles in each synaptic terminal (only
gold particles within 1mm of the synaptic membrane were used for
this analysis). Average values±s.e.m. are plotted for untreated
slices (‘Baseline’, white columns) or for slices treated for 5 min
with NMDA and recovered for 25 min in ACSF (‘þ 25 min’, black
columns); ‘n’ represents number of synaptic terminals. Statistical
significance was calculated according to the Mann–Whitney test.
(C) Quantification of PTEN distribution within the spine. The
distance to the synaptic cleft was calculated for each immunogold
particle before (‘Baseline’, black line) or after NMDA treatment
(‘þ 25 min’, grey line), and plotted as cumulative distributions. The
average thickness of the PSD from our micrographs (37 nm) is
indicated in the plot as a vertical grey bar; ‘n’ represents number
of gold particles. Statistical significance was calculated according to
the Kolmogorov–Smirnov test.
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AMPARs at synapses. AMPARs are believed to cycle continu-
ously in and out of synapses in an activity-independent
manner, which depends on the interaction between the
GluA2 subunit (also known as GluR2;Collingridge et al,
2009) and NSF (N-ethylmaleimide-sensitive fusion protein)
(Nishimune et al, 1998; Song et al, 1998; Luscher et al, 1999).
When this interaction is impaired by intracellular infusion of
a peptide containing the NSF-binding sequence of GluA2
(pep2m/G10), AMPAR-mediated synaptic transmission
rapidly ‘runs down’ as the receptors continue to be inter-
nalized, but fail to be reinserted at the synaptic membrane
(Nishimune et al, 1998; Luscher et al, 1999). We have used
the same approach to determine whether PTEN affects the
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Figure 5 Effects of GFP-PTEN expression on synaptic transmission. (A) Sample traces of evoked AMPAR- and NMDAR-mediated synaptic
responses recorded at 60 or þ 40 mV, respectively, from CA1 neurons expressing GFP-PTEN and neighbouring control (uninfected) neurons.
(B) Average AMPAR-mediated current amplitude (peak of the synaptic response recorded at 60 mV) from pairs of uninfected and GFP-PTEN-
expressing neurons. For (B, C, E, F, H, I),‘n’ represents number of pairs of cells, and statistical significance was determined with the Wilcoxon’s
test for paired data. (C) Average NMDAR-mediated current amplitude (recorded at þ 40 mV and measured at a latency of 60 ms) from pairs of
uninfected and GFP-PTEN-expressing neurons. (D–F) Similar to (A–C), with infected neurons expressing GFP-PTEN-C124S. (G–I) Similar to
(A–C), with infected neurons expressing GFP-PTEN-DPDZ. (J) Time course of AMPAR-mediated synaptic responses recorded from CA1
neurons expressing GFP-PTEN or from control (uninfected) neurons, during whole-cell pipette infusion of the GluA2-NSF interfering peptide
(pep2 m). Response amplitude is normalized to a 2 min baseline from the beginning of the recording; ‘n’ represents number of cells. Inset:
sample traces averaged from the first 5 min of the recording (thin lines) or from the last 5 min of the time course (thick lines). (K) Paired-pulse
facilitation (PPF) recorded from control (uninfected) neurons or from neurons expressing GFP-PTEN. PPF is calculated as the ratio of the
amplitude of the second response versus that of the first one; ‘n’ represents number of cells. Inset: representative traces of evoked AMAR-
mediated responses with an interstimulus interval of 200 ms.
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recorded AMPAR-mediated synaptic responses from CA1
hippocampal neurons infected with PTEN, whereas infusing
them with the GluA2-NSF peptide pep2m/G10. The peptide
produced a fast ‘run-down’ of synaptic transmission in the
uninfected cells (Figure 5J, white symbols), as expected. This
‘run-down’ was virtually identical in the cells expressing
PTEN (Figure 5J, black symbols), indicating that PTEN
activity does not alter the continuous cycling of AMPARs.
Although PTEN was expressed in postsynaptic CA1 neu-
rons, we examined whether presynaptic properties may have
been altered retrogradely (Regalado et al, 2006; Futai et al,
2007). As shown in Figure 5K, paired-pulse facilitation (PPF),
an indicator of presynaptic function, was unaltered by PTEN
overexpression.
The PIP3 pathway is also involved in the regulation of gene
expression (Brunet et al, 2001). Nevertheless, overnight over-
expression of PTEN did not affect the expression levels of
GluA1 and GluA2 subunits of AMPA receptors, or their
phosphorylation state (phospho-Ser 831 and 845 for GluA1,
and phospho-Ser 880 for GluA2; Supplementary Figure 5).
Therefore, these combined data strongly suggest that
PTEN has a specific postsynaptic function at excitatory
hippocampal synapses.
PTEN activity is required for NMDA receptor-dependent
LTD
The depression of AMPAR responses as a consequence of
PTEN overexpression led us to think that this phosphatase
may have a function in long-lasting changes of synaptic
strength, and particularly, in LTD. In addition, the NMDA
treatments that we found to regulate the association of PTEN
with postsynaptic elements (Figures 1 and 3) and its redis-
tribution in spines (Figures 2 and 4) are known to lead to
synaptic depression (Lee et al, 1998).
To directly test a potential function of PTEN in LTD in
hippocampal slices, we used a bis-peroxivanadium deriva-
tive, bpV(HO)pic, which has been shown to specifically
inhibit PTEN when used at a low nanomolar concentrations
(Schmid et al, 2004) (see Supplementary Figure 6 for a test of
bpV(HO)pic specificity). LTD was induced on control or on
bpV(HO)pic-pretreated slices by pairing presynaptic stimula-
tion (1 Hz, 500 pulses) with moderate postsynaptic depolari-
zation (40 mV). Interestingly, when compared with control
cells, inhibition of PTEN with bpV(HO)pic greatly reduced
the magnitude of LTD (Figure 6A and D), suggesting that
PTEN activity is necessary for LTD in CA1 hippocampal



























































































































Figure 6 PTEN lipid phosphatase activity is required for LTD. (A–C) LTD was induced in CA1 hippocampal neurons pretreated with the PTEN
inhibitor bpV(HO)pic (A) or expressing the PTEN point mutants C124S (B) or G129E (C). The results from control neurons (uninfected or
untreated) were carried out in an interleaved manner with their corresponding infected or treated neurons. Amplitude of the synaptic responses
is normalized to a 10 min baseline. Insets: sample traces averaged from the baseline (thin lines) or from the last 10 min of the recording
(thick lines). (D) Average of AMPAR-mediated responses collected from the last 10 min of the recording and normalized to the baseline. Left
columns (LTD, paired) correspond to the stimulation pathway in which postsynaptic depolarization (40 mV) was paired to low-frequency
stimulation (1 Hz). Right columns (control, unpaired) correspond to the pathway that was not stimulated during depolarization; ‘n’ represents
number of cells.
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control pathway—Figure 6D—or on basal synaptic transmis-
sion—not shown). Similar blockade of LTD expression was
observed when the PTEN inhibitor was applied only during
the time of LTD induction (see Supplementary Figure 7).
As an alternative approach to test the function of PTEN in
LTD, we carried out similar experiments with neurons
expressing the catalytically dead mutant PTEN-C124S. It
is important to keep in mind that this mutant did not have
any effect on basal AMPAR- or NMDAR-mediated transmis-
sion (Figure 5D–F). Interestingly, PTEN-C124S displayed a
dominant negative effect on LTD. That is, PTEN-C124S
expression blocked LTD to a similar extent as the PTEN
inhibitor (Figure 6B and D).
PTEN is known to have both lipid and protein phosphatase
activity, as well as phosphatase-independent functions
(Tamguney and Stokoe, 2007). To test whether the function
of PTEN in LTD was specifically dependent on its PIP3-
phosphatase activity, we used a lipid phosphatase PTEN
mutant that retains its protein phosphatase activity:
PTEN-G129E (Myers et al, 1998). Similar to our results with
PTEN-C124S, neurons expressing PTEN-G129E did not
undergo long-lasting depression (Figure 6C and D). Taken
together, these pharmacological and genetic approaches
indicate that PTEN lipid phosphatase activity is required for
LTD in CA1 hippocampal synapses.
To further explore the function of PTEN in synaptic depres-
sion, we evaluated LTD in neurons overexpressing wild-type
PTEN. As shown in Supplementary Figure 8, PTEN over-
expression did not alter LTD expression. Taking into account
that PTEN-overexpressing neurons display reduced AMPAR-
mediated synaptic transmission under basal conditions
(Figure 5A and B), these data suggest either that PTEN-
induced depression does not saturate subsequent LTD
expression, or, alternatively, that overexpressed PTEN acts
on a different pool of AMPARs from those removed during
synaptically induced LTD.
PTEN is neither required for LTP nor for metabotropic
glutamate receptor-dependent LTD
After having established the importance of PTEN for LTD, we
wished to investigate whether PTEN activity is required for
LTP, another paradigmatic form of NMDAR-dependent synap-
tic plasticity. To this end, we evaluated the effect of the
catalytically dead mutant, PTEN-C124S, on LTP in CA1
hippocampal neurons. LTP was induced on infected and
uninfected CA1 neurons by pairing presynaptic stimulation
(3 Hz, 300 pulses) with postsynaptic depolarization (0 mV).
As shown in Figure 7A and C, no significant difference was
found between uninfected (control) and infected (PTEN-
C124S-expressing) neurons. PTEN-C124S did not have any
effect on the non-potentiated (unpaired) pathway either
(Figure 7C). Virtually identical results were obtained with
the specific PTEN inhibitor bpV(HO)pic (Figure 7B and C).
Therefore, these data indicate that PTEN is required specifi-
cally for LTD, and not for other forms of NMDAR-dependent
synaptic plasticity.
In addition, we tested whether PTEN would be required for
another prominent form of LTD in CA1 hippocampal sy-
napses, which is dependent on the activation of metabotropic
glutamate receptors (mGluRs) (Oliet et al, 1997; Palmer et al,
1997). mGluR-dependent LTD was induced by bath applica-
tion of 50mM DHPG (group I mGluR agonist) in the presence
of 100 mM AP5 (NMDAR antagonist) (see Materials and
methods). As shown in Figure 7D and F, neurons expressing
the catalytically dead PTEN-C124S displayed similar depres-
sion to the control, uninfected neurons. Again, identical
results were obtained when blocking PTEN activity pharma-
cologically (Figure 7E and F). Therefore, we conclude that
PTEN is not required for mGluR-dependent LTD in CA1
neurons.
Involvement of PDZ-dependent interactions of PTEN
during NMDAR-dependent LTD
Our electrophysiological data shown above indicate that
PTEN activity is specifically required for NMDAR-dependent
LTD, but not for basal synaptic transmission or other forms of
synaptic plasticity. In part, these conclusions are based on the
observation that catalytically inactive forms of PTEN have a
dominant negative effect on endogenous PTEN to block
NMDAR-dependent LTD (Figure 6B and C). In other words,
these PTEN mutants appear to be competing with endogen-
ous PTEN for some important interaction required for LTD.
An obvious candidate for this interaction is the PDZ motif at
the C-terminus of PTEN, which we have found to mediate the
anchoring of PTEN in the spine and its association with PSD-
95 upon NMDAR activation (Figure 2).
To investigate whether PDZ-dependent interactions of
PTEN are important for its function in LTD, we tested
whether the dominant negative effect of PTEN-C124S re-
quires its PDZ C-terminal motif. To this end, we generated a
catalytically dead mutant (C124S) lacking the PDZ ligand
motif (-ITKV*). This mutant (PTEN-C124S-DPDZ) did not
affect basal synaptic transmission mediated by AMPA or
NMDA receptors (Figure 8A–C), consistent with the results
with PTEN-C124S (Figure 5D–F). Then, we carried out LTD
experiments in CA1 neurons expressing this truncated, cata-
lytically dead mutant. Interestingly, neurons expressing
PTEN-C124S-DPDZ displayed normal LTD, undistinguishable
from uninfected cells (Figure 8D and E). Therefore, these
results suggest that the C-terminal PDZ-binding motif of
PTEN is necessary for its function in LTD.
Discussion
In this study, we show that the lipid phosphatase PTEN,
typically associated with cell growth and proliferation, is
recruited to synapses and is required for the expression of
NMDAR-dependent LTD. This is based on three main lines of
evidence. First, using electrophysiological assays on hippo-
campal slices, we have determined that enhancement of
PTEN activity is sufficient to depress AMPAR-mediated sy-
naptic transmission, and that PTEN lipid phosphatase activity
is specifically required for NMDAR-dependent LTD. Second,
a combination of live imaging, electron microscopy and
biochemical assays indicate that NMDAR activation triggers
a PDZ-dependent association between PTEN and the synaptic
scaffold, which anchors PTEN at the postsynaptic terminal.
And third, this PDZ-dependent interaction appears to be
involved in PTEN’s action during LTD, as a dominant nega-
tive mutant of PTEN is ineffective when lacking its PDZ
motif. These combined results reveal PTEN as a regulated
signalling molecule at synapses, which is recruited to the
postsynaptic membrane in an activity-dependent manner and
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is required for the modulation of synaptic activity during
plasticity.
An important aspect of this work is the identification of a
precise synaptic function for PTEN during plasticity. PTEN is
a well-known negative regulator of PI3K signalling, and as
such, it controls multiple aspects of neuronal development,
including neurite growth, axon specification, dendritic arbori-
zation and growth cone dynamics (Jaworski et al, 2005;
Chadborn et al, 2006; Kwon et al, 2006). In this context,
it may not be surprising that earlier studies using heterozygous
or mosaic PTEN knock-out mice have reported multiple
impairments in synaptic function, including basal transmis-
sion, PPF, LTP and LTD (Wang et al, 2006; Fraser et al, 2008).
These complex phenotypes are probably related to general
neuronal dysfunctions caused by alterations in the PIP3 path-
way during development. Our data presented here indicate
that semi-acute (15–20 h) blockade of PTEN activity, either
through pharmacological or genetic approaches, results in a
very specific impairment of NMDAR-dependent LTD, without
affecting basal synaptic transmission, NMDAR function, LTP,
mGluR-dependent LTD or presynaptic function. Therefore, we
believe that these results are revealing an acute and distinct
function of PTEN at otherwise unperturbed synapses.
Perhaps one of the most surprising observations of this
study is the recruitment of PTEN to the postsynaptic complex
in response to NMDAR activation. PTEN was already known
to interact with PDZ domain-containing proteins in different
cell types (Bonifant et al, 2007). However, no such interaction
had been reported in neurons before this work. We now
identify PSD-95 as a potential PDZ synaptic partner for PTEN.
This association is very low under basal conditions, but it is
rapidly triggered upon NMDAR activation. We should also
point out that our results do not prove a direct interaction
between PTEN and PSD-95. Given the dense network of
interactions present at the postsynaptic membrane, it is
possible that the association between PTEN and PSD-95 is
just reflecting the recruitment of PTEN to the postsynaptic
scaffold. Indeed, this recruitment may be maintained by
different sets of interactions at different time points, as the
anchoring of PTEN in spines and its presence at the PSD
(fluorescence and electron microscopy data) appears to be
longer lasting than its association with PSD-95 (co-immuno-
precipitations). This interpretation would also fit with earlier
reports showing that PSD-95 is partially removed from spines
during LTD (Horne and Dell’Acqua, 2007; Bhattacharyya et al,

















































































































































































Figure 7 PTEN activity is not required for LTP or for mGluR-dependent LTD. (A) LTP was induced in CA1 hippocampal neurons expressing
GFP-PTEN-C124S (black symbols) or in control (uninfected) neurons (white symbols). Amplitude of the synaptic response is normalized to
a 2 min baseline. Inset: sample traces averaged from the baseline (thin lines) or from the last 10 min of the recording (thick lines). (B) Similar
to (A), using slices pretreated with the PTEN inhibitor bpV(HO)pic or control (untreated) slices. (C) Average of AMPAR-mediated responses
collected from the last 10 min of the recording (25–35 min in (A), 40–50 min in (B)) and normalized to the baseline. Left and right columns
(LTP, paired) correspond to the stimulation pathway in which postsynaptic depolarization (0 mV) was paired to presynaptic stimulation (3 Hz).
Middle columns (control, unpaired) correspond to the pathway that was not stimulated during depolarization; ‘n’ represents number of cells.
(D) mGluR-dependent LTD was induced by bath application of 50 mM DHPG (agonist of type I mGluR receptors). Recordings were carried out in
the presence of 100mM AP5 (NMDAR antagonist) (see Materials and methods). Synaptic responses were normalized to a 10 min baseline before
DHPG application for uninfected neurons (white symbols) and for GFP-PTEN-C124S-expressing neurons (black symbols). Inset: sample traces
averaged from the baseline (thin lines) or from the last 10 min of the recording (thick lines). (E) Similar to (D), using slices pretreated with the
PTEN inhibitor bpV(HO)pic or control (untreated) slices. (F) Average of AMPAR-mediated responses collected from the last 10 min of the
recording (50–60 min in (D), 35–45 in (E)) and normalized to the baseline.
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The regulation of PTEN interactions during LTD is likely to
occur at multiple levels. For example, we have observed that
NMDAR activation triggers a transient mobilization of PTEN
within dendritic spines, which precedes its PDZ-dependent
anchoring. Therefore, it is likely that the regulation of PTEN
in response to NMDAR activation will involve release from
basal retention interactions, as well as association with new
synaptic partners. In fact, the initial mobilization of PTEN
may facilitate its subsequent association with PSD-95 at the
PSD. Undoubtedly, further work will be required to dissect
the details of this dynamic behaviour of PTEN within den-
dritic spines. Nevertheless, these new results strengthen the
emerging notion that PSD-95 acts as an important organizer
of synaptic signalling during LTD (Xu et al, 2008;
Bhattacharyya et al, 2009).
What are the functional consequences of this activity-
dependent recruitment of PTEN to the postsynaptic complex?
It is reasonable to hypothesize that binding of PTEN to the
postsynaptic complex positions PTEN in close proximity to
the postsynaptic membrane, which in turn would facilitate
access to its PIP3 substrate during NMDAR-dependent LTD.
On the one hand, the stabilization of PTEN in close proximity
to its substrate could have significant effects on its catalytic
efficiency. But perhaps more importantly, this mechanism
would also restrict PTEN action to the postsynaptic mem-
brane of the synapses being activated. In other words, this
regulated PDZ-dependent recruitment of PTEN may provide
the means to achieve synapse-specific modulation of PIP3
signalling during plasticity.
And finally, how does PTEN activity lead to LTD expres-
sion? We have recently described that downregulation of PIP3
leads to the redistribution of AMPARs from the postsynaptic
membrane into the extrasynaptic surface of the spine (Arendt
et al, 2010). On the one hand, this short-range movement is
expected to depress synaptic transmission, as perisynaptic
AMPARs will not be significantly activated by synaptically
released glutamate (Raghavachari and Lisman, 2004). On the
other hand, this redistribution of AMPARs may facilitate their
access to perisynaptic endocytic hotspots (Blanpied et al,
2002; Petralia et al, 2003; Racz et al, 2004), and, therefore,
may act as an initial step preceding AMPAR internalization.
A downstream effector of the PIP3 pathway is glycogen
synthase kinase-3 b (GSK-3b). Upregulation of PIP3 levels
leads to activation of the Ser/Thr kinase Akt, which in turn
phosphorylates and inactivates GSK-3b (Cross et al, 1995).
Therefore, PTEN will act as a positive regulator of GSK-3b, by
reducing PIP3 levels with the concomitant decrease in Akt
activation and dephosphorylation (activation) of GSK-3b.
Interestingly, GSK-3b has been recently shown to be activated
(dephosphorylated) upon LTD induction, and this activation
was required for the specific expression of LTD (versus LTP)


















































































































Figure 8 Involvement of the PDZ motif of PTEN in LTD. (A) Sample traces of evoked AMPAR- and NMDAR-mediated synaptic responses
recorded at 60 or þ 40 mV, respectively, from CA1 neurons expressing GFP-PTEN-C124S-DPDZ and neighbouring control (uninfected)
neurons. (B) Average AMPAR-mediated current amplitude (peak of the synaptic response recorded at 60 mV) from pairs of uninfected and
GFP-PTEN-C124S-DPDZ-expressing neurons. For (B) and (C),‘n’ represents number of pairs of cells, and statistical significance was determined
with the Wilcoxon’s test. (C) Average NMDAR-mediated current amplitude (recorded at þ 40 mV and measured at a latency of 60 ms) from
pairs of uninfected and GFP-PTEN-C124S-DPDZ-expressing neurons. (D) LTD was induced in CA1 hippocampal neurons expressing GFP-PTEN-
C124S-DPDZ (black symbols) or in control (uninfected) neurons (white symbols). Amplitude of the synaptic responses is normalized to
a 10 min baseline. Insets: sample traces averaged from the baseline (thin lines) or from the last 10 min of the recording (thick lines). (E) Average
of AMPAR-mediated responses collected from the last 10 min of the recording and normalized to the baseline. Left columns (LTD, paired)
correspond to the stimulation pathway in which postsynaptic depolarization (40 mV) was paired to low-frequency stimulation (1 Hz). Right
columns (control, unpaired) correspond to the pathway that was not stimulated during depolarization; ‘n’ represents number of cells.
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recruitment of PTEN to the postsynaptic membrane during
LTD is relayed through the PIP3 pathway to activate GSK-3b at
specific synapses. This mechanism would be consistent with
the presence of GSK-3b in synaptosomal preparations and
dendritic spines (Hooper et al, 2007; Peineau et al, 2007).
Therefore, our results propose a specific mechanism for the
synaptic compartmentalization of PIP3 signalling during plas-
ticity.
In addition, it has been recently shown that LTD requires
PIP2 turnover by phospholipase C (PLC), which leads to the
loss of the scaffolding molecules AKAP79 and PSD-95 from
synapses and initiates the structural remodelling of the spine
(Horne and Dell’Acqua, 2007). Taking together, Dell’Acqua’s
study and ours would suggest an interesting relay of phos-
phoinositide metabolism during LTD, which would involve
degradation of PIP3 into PIP2 (through PTEN) for initial
AMPAR depression, and subsequent PIP2 turnover (through
PLC) for further structural and functional changes in the spine.
In summary, this work has offered new insights into the
organization of synaptic signalling during plasticity and has
revealed distinct functions for the tumour suppressor PTEN
as a critical mediator of LTD in hippocampal neurons.
Materials and methods
Expression of recombinant proteins and antibodies used in this
study are described in Supplementary data.
Co-immunoprecipitations and pharmacological treatments
Hippocampal slices were transferred to a submersion-type holding
chamber containing artificial cerebrospinal fluid (ACSF, composi-
tion described in Supplementary data), gassed with 5% CO2/95%
O2 at 301C. Slices were equilibrated in the holding chamber for
10 min before each experiment and were transferred to a separate
chamber containing ACSF plus 20mM NMDA, 100 mM AMPA or
50 mM KCl, in which they remained for 5 min. After these
treatments, some slices were taken immediately for homogeniza-
tion in a buffer containing 10 mM HEPES, 150 mM NaCl, 10 mM
EDTA, 0.1 mM phenylmethanesulphonylfluoride, 2mg/ml of chymo-
statin, leupeptin, anti-pain and pepstatin, 10 mM NaF, 1 mM
microcystin LR, 0.5mM calyculin A and 1% Triton X-100. Other
slices were transferred to another chamber containing ACSF, for
variable recovery times, as indicated in each experiment. Total
protein extracts were prepared in the buffer described above. For
immunoprecipitations, 200–300mg of protein extracts were incu-
bated with the corresponding antibodies and with 40 ml of protein
G-sepharose beads (50%) (Amersham Biosciences) for 4 h at 41C.
These samples were then washed and immunoprecipitated proteins
were eluted by boiling in 1x Laemmli sample buffer and separated
by SDS–PAGE. Visualization of immunoprecipitated proteins was
performed by western blot developed with chemiluminescence or
with the Odyssey fluorescence system, and quantified with Image J
under linear conditions.
Electrophysiology
Voltage-clamp whole-cell recordings were obtained from nearby
infected and uninfected CA1 pyramidal neurons, under visual
guidance using fluorescence and transmitted light illumination.
Composition of ACSF and internal solution and description of
synaptic plasticity protocols are included in Supplementary data.
Bipolar stimulating electrodes were placed over Schaffer collateral
fibres between 250 and 300mm from the CA1 recorded cells, and
synaptic responses were evoked with single voltage pulses (200ms,
up to 30 V). Responses were collected at 60 and þ 40 mV and
averaged over 50–100 trials. All electrophysiological data were
collected with pCLAMP software (Molecular Devices).
Fluorescence recovery after photobleaching
Hippocampal slices (5–7 DIV) were perfused with ACSF for 15–30
min. Confocal images of dendritic spines were obtained on an
Olympus FV500 confocal microscope using a 60 oil immersion
objective. Digital images were acquired using the FluoView
software. After acquisition of baseline images, dendritic spines
were photobleached for 5 s (approximate time to completely bleach
fluorescence signal in the spine). Recovery of fluorescence in the
spine was measured from images acquired up to 50 s after the
photobleaching. After collecting several images from dendritic
spines under baseline conditions, the perfusion solution was
switched to an ACSF containing 20 mM NMDA. After 5 min of
NMDA treatment, the slices were washed again with standard ACSF.
Further FRAP images were acquired after 10, 20 and 30 min of the
NMDA treatment. Images were reconstructed and analysed using
NIH Image J software.
Electron microscopy
Rat hippocampus was fixed, dehydrated and processed for
postembedding immunogold labelling as earlier described (Phend
et al, 1995). Immunostaining was done with anti-PTEN antibody
(Neomarkers) followed by an anti-mouse secondary antibody
coupled to 10 nm gold particles (Electron Microscopy Sciences).
Images were acquired with a Philips CM-100 transmission electron
microscope coupled to a Kodak 1.6 Megaplus digital camera.
Quantification of gold particles and distance measurements were
carried out on the digital images using NIH Image J software.
Statistical analysis
Statistical differences were calculated according to non-parametric
tests. Comparisons between multiple groups were carried out with
the Kruskal–Wallis ANOVA. When significant differences were
observed, P-values for pairwise comparisons were calculated
according to two-tailed Mann–Whitney tests (for unpaired data)
or Wilcoxon’s tests (for paired data). Comparisons between
cumulative distributions (Figure 4C) were calculated with the
Kolmogorov–Smirnov test.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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